Industrials · Services-Business Services, NEC · Nasdaq · CIK 1479681 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $148.71Day +5.85%Mkt cap $1.0BP/E (FY) 14.2×1Y +77.0%Off 52W high −27.1%Vol (1Y) 92.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,078 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Price impliesUNDEMANDING · −15.5% growth |
| Short interest15.3% of sh out |
| Days to cover7.6d |
| 13F net flow (QoQ)−0.41% |
| Top-10 13F concentration65.8% |
| Next report (est.)2026-10-29 |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run. Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)14.2× |
| Sales (TTM)$880.0M |
| Earnings (TTM)$96.4M |
| ROE30.7% |
| Net margin8.1% |
| ROIC87.3% |
| YTD−9.7% |
| 1Y+77.0% |
| 3Y+138.1% |
| Since incept. (ann.)−53.3% |
Total return through 2026-07-30 · series begins 2022-04-05. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)92.0% |
| Ann. volatility (3Y)108.0% |
| Sharpe (1Y)1.07 |
| Sharpe (3Y)0.79 |
| Max drawdown (1Y)−54.3% |
| Max drawdown (3Y)−93.1% |
| Beta (3Y vs SPY)2.44 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 379,355 | $36M | 5.44% | +34.7% |
| Pertento Partners LLP | 373,970 | $36M | 5.37% | +15.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | 219,131 | $21M | 3.14% | new |
| AMERICAN CENTURY COMPANIES INC | 203,450 | $19M | 2.92% | +54.1% |
| Topline Capital Management, LLC | 177,800 | $17M | 2.55% | −73.7% |
| STATE STREET CORP | 123,177 | $12M | 1.77% | +41.9% |
| GEODE CAPITAL MANAGEMENT, LLC | 122,113 | $12M | 1.75% | +46.8% |
| MILLENNIUM MANAGEMENT LLC | 89,571 | $9M | 1.29% | +20.5% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-04-30 | $6.52 | +95.8% | $216.5M | +2.2% |
| 2025-12-31 | 2026-03-05 | — | — | $151.7M | −41.1% |
| 2025-09-30 | 2025-11-19 | $7.76 | — | $267.8M | +239.9% |
| 2025-06-30 | 2025-11-18 | −$2.95 | — | $244.0M | +220.7% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-10-29 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Hospital Division 96% · Population Health Management Division 4%
product & service · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
| Total debt / EBITDA0.14× |
| Sales growth 3Y58.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
